NeuroGenesis Bio
NY - RochesterBiotechnology
Focus: NeuroGenesis Bio is a public biotech company founded in 2007 specializing in bone marrow cell therapy with a focus on oncology, gene therapy, cell therapy, and musculoskeletal indications. The company operates from Rochester, NY with a commercial-stage portfolio anchored by two mitomycin-based products.
Profile data last refreshed 1h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About NeuroGenesis Bio
AI assessmentNot HiringNo open roles listed right now. Follow NeuroGenesis Bio to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
2 in 5yr
JELMYTO
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Stable
Peak4.5yr
Peak-stage product with 7+ years of patent exclusivity remaining, serving as the company's primary revenue engine and market anchor.
Help build intelligence for NeuroGenesis Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.